This revised international guideline gives a peer-reviewed evidence-based statement for the guidance of practice for clinical neurologists, geriatricians, psychiatrists, and other specialist physicians responsible for the care of patients with Alzheimer’s disease. Mild cognitive impairment and non-Alzheimer dementias are not included in this guideline.
The recommendations for clinical diagnosis, blood tests, neuropsychology, neuroimaging, electroencephalography, cerebrospinal fluid (CSF) analysis, genetic testing, disclosure of diagnosis, treatment of Alzheimer’s disease, behavioural and psychological symptoms in dementia, legal issues, counselling and support for caregivers were all revised as compared with the previous EFNS guideline.
The assessment, interpretation, and treatment of symptoms, disability, needs, and caregiver stress during the course of Alzheimer’s disease require the contribution of many different professionals. These professionals should ideally adhere to the European Federation of the Neurological Societies (EFNS) guidelines to improve the diagnosis and management of Alzheimer’s disease.
“Summary: These revised guidelines include recommendations for genetic testing”.
Hort, J. O’Brien, JT. [and] Gainotti, G. (2010). EFNS Scientist Panel on Dementia. EFNS guidelines for the diagnosis and management of Alzheimer’s disease. The European Journal of Neurology, October 2010, Vol.17(10), pp.1236-48.